milrinone has been researched along with Angina Pectoris in 2 studies
Angina Pectoris: The symptom of paroxysmal pain consequent to MYOCARDIAL ISCHEMIA usually of distinctive character, location and radiation. It is thought to be provoked by a transient stressful situation during which the oxygen requirements of the MYOCARDIUM exceed that supplied by the CORONARY CIRCULATION.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kim, JH | 1 |
| Ham, BM | 1 |
| Kim, YL | 1 |
| Bahk, JH | 1 |
| Ryu, HG | 1 |
| Jeon, YS | 1 |
| Kim, KB | 1 |
| Mitrovic, V | 1 |
| Stöhring, R | 1 |
| Schlepper, M | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| 2- Inhaled Milrinone Prevents the Increase in Pulmonary Artery Pressure After CPB[NCT00819377] | Phase 2 | 124 participants (Anticipated) | Interventional | 2009-02-28 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
2 trials available for milrinone and Angina Pectoris
| Article | Year |
|---|---|
Prophylactic milrinone during OPCAB of posterior vessels: implication in angina patients taking beta-blockers.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Adrenergic beta-Antagonists; Aged; Angina Pectoris; Cardiotonic | 2003 |
The use of intravenous milrinone in chronic symptomatic ischemic heart disease.
Topics: Aged; Angina Pectoris; Atrial Natriuretic Factor; Cardiotonic Agents; Coronary Disease; Drug Evaluat | 1991 |